MDBros｜Paradigm Shifts in Healthcare: Who It's For and Who Sponsors It

Est. audience: 100
Apple rating: 0 from 0
Cadence: Weekly
Latest: 2026-10-31
By: MDBros
Based on: 12 recent episodes

Covers: Medical innovation case studies analyzing clinical trial evidence, regulatory hurdles, reimbursement policies, and healthcare startup business models.
For: Healthcare entrepreneurs, biotech investors, clinicians, and medical device commercialization professionals.
Best for: Biotech founders, medtech executives, and healthcare investors evaluating clinical evidence and market feasibility.
Skip if: General consumers seeking basic medical advice or lifestyle wellness tips.

Start with

鹽之有物：向榮的膝關節幹細胞，要先贏過一針生理食鹽水: Deconstructs regenerative medicine export permits, clinical trials, and reimbursement economics.
先准後奏：仲恩的幹細胞，在日本賭一張附條件的藥證: Examines conditional approval pathways in Japan and Taiwan alongside stem cell clinical evidence.
拿到了全世界第一個外骨骼代碼，然後公司沒了｜Ekso Bionics、機器人步態訓練的證據，與「給付就是答案」這個誤會: Explains why securing insurance reimbursement codes still failed to save a medtech business.

Healthcare Technology Venture Capital Startups

Summarised by AI from 12 recent episodes. Audience estimate and Apple rating from Podscan, checked 2026-11-03; treat the estimate as a guide and ask the show for its own numbers. Prices are not included. Report a mistake.